Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters











Database
Language
Publication year range
2.
Sci Rep ; 10(1): 21228, 2020 12 04.
Article in English | MEDLINE | ID: mdl-33277554

ABSTRACT

Ascorbic acid (AA, vitamin C) serves as a cofactor for ten-eleven translocation (TET) enzymes and induces DNA demethylation in vitro. However, its role in DNA demethylation in vivo remains unclear. We previously reported that DNA demethylation in the mouse liver was enhanced during the suckling period. Therefore, we hypothesized that DNA demethylation is enhanced in an AA-dependent manner during the suckling period. To examine our hypothesis, we employed wild-type (WT) mice, which synthesize AA, and senescence marker protein-30/gluconolactonase (SMP30/GNL) knockout (KO) mice, which cannot synthesize AA, and analyzed the DNA methylation status in the livers of offspring in both the suckling period and adulthood. SMP30/GNL KO offspring showed DNA hypermethylation in the liver possibly due to low plasma and hepatic AA levels during the suckling period despite the administration of rescue-dose AA to dams. Furthermore, DNA hypermethylation of the fibroblast growth factor 21 gene (Fgf21), a PPARα target gene, persisted into adulthood. In contrast, a high-dose AA administration to SMP30/GNL KO dams during the lactation period restored DNA demethylation in the livers of offspring. Even though a slight increase was observed in plasma AA levels with the administration of rescue-dose AA to WT dams during the gestation and lactation periods, DNA demethylation in the livers of offspring was minimally enhanced. The present results demonstrate that AA intake during the suckling period is required for proper DNA demethylation in the liver.


Subject(s)
Ascorbic Acid/administration & dosage , Ascorbic Acid/metabolism , DNA Demethylation , Gene Expression Regulation, Developmental/genetics , Liver/metabolism , Animals , Animals, Suckling/metabolism , Ascorbic Acid/blood , Calcium-Binding Proteins/genetics , Calcium-Binding Proteins/metabolism , Carboxylic Ester Hydrolases/genetics , Carboxylic Ester Hydrolases/metabolism , Embryo, Mammalian/drug effects , Embryo, Mammalian/metabolism , Fatty Acids/blood , Fatty Acids/metabolism , Female , Fibroblast Growth Factors/metabolism , Gene Expression Regulation, Developmental/drug effects , High-Throughput Nucleotide Sequencing , Intracellular Signaling Peptides and Proteins/genetics , Intracellular Signaling Peptides and Proteins/metabolism , Lactation/drug effects , Lipid Metabolism/genetics , Liver/enzymology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Microarray Analysis , Milk/drug effects , Milk/metabolism , PPAR alpha/metabolism , Signal Transduction/drug effects , Signal Transduction/genetics
3.
Intern Med ; 59(14): 1769-1772, 2020 Jul 15.
Article in English | MEDLINE | ID: mdl-32296002

ABSTRACT

Methicillin-resistant Staphylococcus aureus USA300, belonging to sequence type (ST) 8, is a rare cause of necrotizing fasciitis in the USA. We herein report a case of monomicrobial Fournier's gangrene caused by an ST8, methicillin-susceptible Staphylococcus aureus (designated ksw1). Whole-genome sequencing and analyses for virulence determinants revealed that, unlike USA300, ksw1 lacked virulence genes, such as Panton-Valentine leukocidin and SCCmec, while harboring the toxic shock syndrome toxin-1 gene. These genomic features correlate with ST8 CA-MRSA/J, which is the major genotype of ST8 in Japan.


Subject(s)
Bacterial Toxins/adverse effects , Enterotoxins/adverse effects , Fournier Gangrene/etiology , Fournier Gangrene/microbiology , Leukocidins/adverse effects , Methicillin/pharmacology , Staphylococcal Infections/drug therapy , Staphylococcus aureus/genetics , Superantigens/adverse effects , Aged , Fournier Gangrene/diagnosis , Fournier Gangrene/epidemiology , Genotype , Humans , Japan/epidemiology , Male , Virulence Factors/genetics
4.
Sci Rep ; 10(1): 5181, 2020 03 20.
Article in English | MEDLINE | ID: mdl-32198422

ABSTRACT

Recently, we reported PPARα-dependent DNA demethylation of the Fgf21 promoter in the postnatal mouse liver, where reduced DNA methylation is associated with enhanced gene expression after PPARα activation. However, there is no direct evidence for the effect of site-specific DNA methylation on gene expression. We employed the dCas9-SunTag and single-chain variable fragment (scFv)-TET1 catalytic domain (TET1CD) system to induce targeted DNA methylation of the Fgf21 promoter both in vitro and in vivo. We succeeded in targeted DNA demethylation of the Fgf 21 promoter both in Hepa1-6 cells and PPARα-deficient mice, with increased gene expression response to PPARα synthetic ligand administration and fasting, respectively. This study provides direct evidence that the DNA methylation status of a particular gene may determine the magnitude of the gene expression response to activation cues.


Subject(s)
DNA Demethylation , Fibroblast Growth Factors/genetics , Animals , CRISPR-Cas Systems , Clustered Regularly Interspaced Short Palindromic Repeats , DNA Methylation , Epigenesis, Genetic , Epigenome , Fibroblast Growth Factors/metabolism , Gene Editing/methods , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , PPAR alpha/genetics , PPAR alpha/metabolism , Promoter Regions, Genetic/genetics
5.
Thyroid ; 28(3): 395-406, 2018 03.
Article in English | MEDLINE | ID: mdl-29415629

ABSTRACT

BACKGROUND: Thyroid hormones are essential for normal development of the central nervous system (CNS). Experimental rodents have shown that even a subtle thyroid hormone insufficiency in circulating maternal thyroid hormones during pregnancy may adversely affect neurodevelopment in offspring, resulting in irreversible cognitive deficits. This may be due to the persistent reduced expression of the hippocampal brain-derived neurotrophic factor gene Bdnf, which plays a crucial role in CNS development. However, the underlying molecular mechanisms remain unclear. METHODS: Thiamazole (MMI; 0.025% [w/v]) was administered to dams from two weeks prior to conception until delivery, which succeeded in inducing mild maternal hypothyroxinemia during pregnancy. Serum thyroid hormone and thyrotropin levels of the offspring derived from dams with mild maternal hypothyroxinemia (M offspring) and the control offspring (C offspring) were measured. At 70 days after birth, several behavior tests were performed on the offspring. Gene expression and DNA methylation status were also evaluated in the promoter region of Bdnf exon IV, which is largely responsible for neural activity-dependent Bdnf gene expression, in the hippocampus of the offspring at day 28 and day 70. RESULTS: No significant differences in serum thyroid hormone or thyrotropin levels were found between M and C offspring at day 28 and day 70. M offspring showed an impaired learning capacity in the behavior tests. Hippocampal steady-state Bdnf exon IV expression was significantly weaker in M offspring than it was in C offspring at day 28. At day 70, hippocampal Bdnf exon IV expression at the basal level was comparable between M and C offspring. However, it was significantly weaker in M offspring than in C offspring after the behavior tests. Persistent DNA hypermethylation was also found in the promoter region of Bdnf exon IV in the hippocampus of M offspring compared to that of C offspring, which may cause the attenuation of Bdnf exon IV expression in M offspring. CONCLUSIONS: Mild maternal hypothyroxinemia induces persistent DNA hypermethylation in Bdnf exon IV in offspring as epigenetic memory, which may result in long-term cognitive disorders.


Subject(s)
Brain-Derived Neurotrophic Factor/metabolism , DNA Methylation , Hippocampus/metabolism , Hypothyroidism/metabolism , Prenatal Exposure Delayed Effects/metabolism , Thyroxine/blood , Animals , Behavior, Animal/physiology , Brain-Derived Neurotrophic Factor/genetics , Female , Hypothyroidism/genetics , Maze Learning/physiology , Mice , Pregnancy , Prenatal Exposure Delayed Effects/genetics , Rotarod Performance Test
6.
Nat Commun ; 9(1): 636, 2018 02 12.
Article in English | MEDLINE | ID: mdl-29434210

ABSTRACT

The nutritional environment to which animals are exposed in early life can lead to epigenetic changes in the genome that influence the risk of obesity in later life. Here, we demonstrate that the fibroblast growth factor-21 gene (Fgf21) is subject to peroxisome proliferator-activated receptor (PPAR) α-dependent DNA demethylation in the liver during the postnatal period. Reductions in Fgf21 methylation can be enhanced via pharmacologic activation of PPARα during the suckling period. We also reveal that the DNA methylation status of Fgf21, once established in early life, is relatively stable and persists into adulthood. Reduced DNA methylation is associated with enhanced induction of hepatic FGF21 expression after PPARα activation, which may partly explain the attenuation of diet-induced obesity in adulthood. We propose that Fgf21 methylation represents a form of epigenetic memory that persists into adulthood, and it may have a role in the developmental programming of obesity.


Subject(s)
Epigenesis, Genetic , Fibroblast Growth Factors/genetics , Liver/metabolism , Obesity/genetics , Animals , DNA Methylation , Diet/adverse effects , Female , Fibroblast Growth Factors/metabolism , Gene Expression Regulation , Hepatocytes/metabolism , Humans , Male , Mice , Obesity/etiology , Obesity/metabolism , PPAR alpha/genetics , PPAR alpha/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL